118 related articles for article (PubMed ID: 38518893)
1. Pre-chemoradiotherapy high platelet counts predict jaw osteoradionecrosis in locally advanced nasopharyngeal carcinoma patients.
Somay E; Topkan E; Kucuk A; Ozturk D; Ozkan EE; Ozdemir BS; Besen AA; Mertsoylu H; Pehlivan B; Selek U
J Stomatol Oral Maxillofac Surg; 2024 Jun; 125(3S):101838. PubMed ID: 38518893
[TBL] [Abstract][Full Text] [Related]
2. Pre-chemoradiotherapy low hemoglobin levels indicate increased osteoradionecrosis risk in locally advanced nasopharyngeal cancer patients.
Yilmaz B; Somay E; Topkan E; Pehlivan B; Selek U
Eur Arch Otorhinolaryngol; 2023 May; 280(5):2575-2584. PubMed ID: 36749372
[TBL] [Abstract][Full Text] [Related]
3. Valero's host index is useful in predicting radiation-induced trismus and osteoradionecrosis of the jaw risks in locally advanced nasopharyngeal carcinoma patients.
Topkan E; Somay E; Yilmaz B; Pehlivan B; Selek U
BMC Cancer; 2023 Jul; 23(1):651. PubMed ID: 37438683
[TBL] [Abstract][Full Text] [Related]
4. The predictive value of pretreatment hemoglobin-to-platelet ratio on osteoradionecrosis incidence rates of locally advanced nasopharyngeal cancer patients managed with concurrent chemoradiotherapy.
Yilmaz B; Somay E; Topkan E; Kucuk A; Pehlivan B; Selek U
BMC Oral Health; 2023 Apr; 23(1):231. PubMed ID: 37081475
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for osteoradionecrosis of the jaw in patients with head and neck squamous cell carcinoma.
Kubota H; Miyawaki D; Mukumoto N; Ishihara T; Matsumura M; Hasegawa T; Akashi M; Kiyota N; Shinomiya H; Teshima M; Nibu KI; Sasaki R
Radiat Oncol; 2021 Jan; 16(1):1. PubMed ID: 33402192
[TBL] [Abstract][Full Text] [Related]
6. Preradiation tooth extraction and jaw osteoradionecrosis: Nationwide population-based retrospective study in Taiwan.
Liao PH; Chu CH; Tang PL; Wu PC; Kuo TJ
Clin Otolaryngol; 2020 Nov; 45(6):896-903. PubMed ID: 32738824
[TBL] [Abstract][Full Text] [Related]
7. Utility of pre-chemoradiotherapy Pan-Immune-Inflammation-Value for predicting the osteoradionecrosis rates in locally advanced nasopharyngeal cancers.
Yilmaz B; Somay E; Topkan E; Kucuk A; Pehlivan B; Selek U
Strahlenther Onkol; 2023 Oct; 199(10):910-921. PubMed ID: 37566126
[TBL] [Abstract][Full Text] [Related]
8. Home enteral nutrition may prevent myelosuppression of patients with nasopharyngeal carcinoma treated by concurrent chemoradiotherapy.
Li X; Zhou J; Chu C; You Q; Zhong R; Rao Z; Hu W
Head Neck; 2019 Oct; 41(10):3525-3534. PubMed ID: 31301097
[TBL] [Abstract][Full Text] [Related]
9. Progression and postoperative complications of osteoradionecrosis of the jaw: a 20-year retrospective study of 124 non-nasopharyngeal cancer cases and meta-analysis.
Kang Z; Jin T; Li X; Wang Y; Xu T; Wang Y; Huang Z; Huang Z
BMC Oral Health; 2022 May; 22(1):213. PubMed ID: 35643546
[TBL] [Abstract][Full Text] [Related]
10. Baseline Low Prognostic Nutritional Index Predicts Poor Survival in Locally Advanced Nasopharyngeal Carcinomas Treated With Radical Concurrent Chemoradiotherapy.
Topkan E; Yucel Ekici N; Ozdemir Y; Besen AA; Mertsoylu H; Sezer A; Selek U
Ear Nose Throat J; 2021 Feb; 100(2):NP69-NP76. PubMed ID: 31184210
[TBL] [Abstract][Full Text] [Related]
11. Jaw osteoradionecrosis and dental extraction after head and neck radiotherapy: A nationwide population-based retrospective study in Taiwan.
Kuo TJ; Leung CM; Chang HS; Wu CN; Chen WL; Chen GJ; Lai YC; Huang WC
Oral Oncol; 2016 May; 56():71-7. PubMed ID: 27086489
[TBL] [Abstract][Full Text] [Related]
12. Survival benefit of induction chemotherapy for locally advanced nasopharyngeal carcinoma: prognosis based on a new risk estimation model.
Liu W; Yu B; Luo Y; Li J; Yuan X; Wu S; Liang B; Lv Z; Li Y; Peng X; Lu J; Peng X; Liu X
BMC Cancer; 2021 May; 21(1):639. PubMed ID: 34051750
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in locally advanced nasopharyngeal carcinoma.
Setakornnukul J; Thephamongkhol K
BMC Cancer; 2018 Mar; 18(1):329. PubMed ID: 29587665
[TBL] [Abstract][Full Text] [Related]
14. Tumor-Infiltrating T Cell Receptor-Beta Repertoires are Linked to the Risk of Late Chemoradiation-Induced Temporal Lobe Necrosis in Locally Advanced Nasopharyngeal Carcinoma.
Wu L; Chung YL
Int J Radiat Oncol Biol Phys; 2019 May; 104(1):165-176. PubMed ID: 30654091
[TBL] [Abstract][Full Text] [Related]
15. Predictive potential of pan-immune-inflammation value / hemoglobin index as biomarker for osteoradionecrosis risk in locally advanced nasopharyngeal carcinomas.
Yilmaz B; Somay E; Topkan E; Pehlivan B; Besen AA; Mertsoylu H; Selek U
J Stomatol Oral Maxillofac Surg; 2024 Jan; 125(6):101786. PubMed ID: 38286220
[TBL] [Abstract][Full Text] [Related]
16. Long term complications and prognostic factors in locally advanced nasopharyngeal carcinoma treated with docetaxel, cisplatin, 5-fluorouracil induction chemotherapy followed by concurrent chemoradiotherapy: A retrospective cohort study.
Shim HJ; Kim HJ; Hwang JE; Bae WK; Chung IJ; Lee DH; Mi YT; Lee JK; Lim SC; Chung JW; Cho SH
Medicine (Baltimore); 2020 Dec; 99(49):e23173. PubMed ID: 33285692
[TBL] [Abstract][Full Text] [Related]
17. Comparison of induction chemotherapy plus concurrent chemoradiotherapy and induction chemotherapy plus radiotherapy in locally advanced nasopharyngeal carcinoma.
Wang Q; Xu G; Xia Y; Zuo J; Zeng G; Xue Z; Cao R; Xiong W; Li W
Oral Oncol; 2020 Dec; 111():104925. PubMed ID: 32721816
[TBL] [Abstract][Full Text] [Related]
18. Predictive factors for osteoradionecrosis of the jaws: A retrospective study.
Sathasivam HP; Davies GR; Boyd NM
Head Neck; 2018 Jan; 40(1):46-54. PubMed ID: 29149496
[TBL] [Abstract][Full Text] [Related]
19. Final results of a randomized phase III trial of induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in patients with stage IVA and IVB nasopharyngeal carcinoma-Taiwan Cooperative Oncology Group (TCOG) 1303 Study.
Hong RL; Hsiao CF; Ting LL; Ko JY; Wang CW; Chang JTC; Lou PJ; Wang HM; Tsai MH; Lai SC; Liu TW
Ann Oncol; 2018 Sep; 29(9):1972-1979. PubMed ID: 30016391
[TBL] [Abstract][Full Text] [Related]
20. Can neoadjuvant chemotherapy improve survival in stage T3-4N1 nasopharyngeal carcinoma? A propensity matched analysis.
Wang L; Wu Z; Xie D; Lv S; Xia L; Su Y
Radiat Oncol; 2020 Jul; 15(1):160. PubMed ID: 32615984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]